Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
erlotinib epidermal growth factor receptor small molecule Successful target TTD , drugbank , DGIDB Pancreatic carcinoma[MeSHID:C562463]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of pancreas[MeSHID:D010190]
Pancreas[MeSHID:D010179]
Diagnosis[MeSHID:D003933]
Mutation[MeSHID:D009154]
Neoplasm Metastasis[MeSHID:D009362]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Missense Mutation[MeSHID:D020125]
Deletion Mutation[MeSHID:D017384]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant tumor of colon[MeSHID:D003110]		 1.28 approved,investigational antagonist
erlotinib epidermal growth factor receptor small molecule Successful target TTD , drugbank , DGIDB Pancreatic carcinoma[MeSHID:C562463]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of pancreas[MeSHID:D010190]
Pancreas[MeSHID:D010179]
Diagnosis[MeSHID:D003933]
Mutation[MeSHID:D009154]
Neoplasm Metastasis[MeSHID:D009362]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Missense Mutation[MeSHID:D020125]
Deletion Mutation[MeSHID:D017384]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant tumor of colon[MeSHID:D003110]		 1.28 approved,investigational antagonist,inhibitor
erlotinib nuclear receptor subfamily 1 group i member 2 small molecule NA drugbank Pancreatic carcinoma[MeSHID:C562463]
Neoplasms[MeSHID:D009369]
Malignant neoplasm of pancreas[MeSHID:D010190]
Pancreas[MeSHID:D010179]
Diagnosis[MeSHID:D003933]
Mutation[MeSHID:D009154]
Neoplasm Metastasis[MeSHID:D009362]
Non-Small Cell Lung Carcinoma[MeSHID:D002289]
Missense Mutation[MeSHID:D020125]
Deletion Mutation[MeSHID:D017384]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Malignant tumor of colon[MeSHID:D003110]		 NA approved,investigational agonist
click here to return to the previous page